ATP6V0D2 Antibody - BSA Free

Western Blot: ATP6V0D2 Antibody [NBP1-54595]

Western Blot: ATP6V0D2 Antibody [NBP1-54595] - Titration: 0.2-1 ug/ml, Positive Control: Transfected 293T.

Western Blot: ATP6V0D2 Antibody - BSA Free [NBP1-54595] -

The lack of CD73 leads to increased osteoclastogenesis in vitro. (A) Osteoclast differentiation model in the presence of M-CSF and RANKL. (B) Protein expression with the respective (C) densitometry analysis of CD73 relative to the loading control beta -Tubulin during differentiation of osteoclasts (1–3 days). (D) Identification of activate osteoclasts using TRAP positive staining (upper panels) and Pit resorption assay (lower panels) between WT (left panels) and CD73−/− (right panels). Protein expression of (E) ATP6V0D2 and Cathepsin K in osteoclasts derived from WT or CD73−/− animals with the respective (F, G) densitometry analysis showing fold change relative to beta -tubulin or GAPDH as loading control. Measurements of (H) number of osteoclasts, (I) Osteoclast area (x 103 um), and (J) Osteoclast resorption pit area (x 105 um). Data are presented as mean +/- S.D. (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/38152410), licensed under a CC-BY license. Not internally tested by Novus Biologicals.